Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2011
TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunityAlexander D Stoehr, Carolin T Schoen, Maria M M Mertes, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cellsBaerbel Grueter, Michaela Petter, Takeshi Egawa, et al.Angewandte Chemie (International Ed. in English)|June 21, 2023
Towards a Precise NMR Quantification of Acute Phase Inflammation Proteins from Human SerumAlvaro Mallagaray, Lorena Rudolph, Melissa Lindloge, et al.Biomarker Research|July 14, 2026
Interleukin-10 enhances IgG galactosylation and sialylationHanna B Lunding, Anna M Wasynczuk, Yannic C Bartsch, et al.Nature|November 4, 2014
IgG1 protects against renal disease in a mouse model of cryoglobulinaemiaRichard T Strait, Monica T Posgai, Ashley Mahler, et al.BMC Public Health|July 7, 2022
Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study - a prospective population-based cohort studyAlexander Balck, Bandik Föh, Max Borsche, et al.Experimental Hematology & Oncology|October 7, 2025
Anti-tumor vaccine efficacy depends on adjuvant type and associates with induced IgG subclass and glycosylation profilesSelina Lehrian, Anna Wasynczuk, Janina Petry, et al.BMC Public Health|April 8, 2025
Spreading of SARS-CoV-2 among adult asylum seekers in refugee community shelters in Lübeck, Germany between 2020 and 2022: a mixed-cohort observational and repeated cross-sectional studyDaniel Alvarez-Fischer, Max Borsche, Alexander Balck, et al.Frontiers in Molecular Biosciences|December 23, 2021
Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care PatientsFranziska Schmelter, Bandik Föh, Alvaro Mallagaray, et al.Frontiers in Immunology|January 30, 2023
mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccineJana Sophia Buhre, Tamas Pongracz, Inga Künsting, et al.Pageof 5